EX-FILING FEES
Published on February 28, 2022
EXHIBIT 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Sutro Biopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered(1)(2) |
Proposed Maximum Offering Price Per Unit (3) |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
|||||||||||||||||||||||||||||||
| Newly Registered Securities |
||||||||||||||||||||||||||||||||||||||||||
| Primary Offering of Securities: |
||||||||||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Common Stock, $0.0001 par value per share |
475(r) | $ | | $ | | $ | | | $ | | ||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Preferred Stock, $0.0001 par value per share |
475(r) | | | | | | ||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Debt | Debt Securities | 475(r) | | | | | | ||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Warrants | 475(r) | | | | | | ||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Units | 475(r) | | | | | | ||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Unallocated (Universal) Shelf |
457(o) | $ | 250,000,000 | N/A | $ | 250,000,000 | 0.0000927 | $ | 23,175 | ||||||||||||||||||||||||||||||||
| Primary Offering of Common Stock: | | | ||||||||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Common Stock, par value $0.0001 per share |
457(o) | $ | 100,000,000 | (4) | N/A | $ | 100,000,000 | 0.0000927 | $ | 9,270 | ||||||||||||||||||||||||||||||
| Fees to be Paid |
Total Registration Fee: |
N/A | $ | 350,000,000 | 0.0000927 | $ | 32,445 | |||||||||||||||||||||||||||||||||||
| Carry Forward Securities |
||||||||||||||||||||||||||||||||||||||||||
| Carry Forward Securities |
Equity | Common Stock, par value $0.0001 per share |
457(b) | $ | 100,000,000 | (4) | N/A | $ | 100,000,000 | 424 | (b)(5) | 333-255014 | |
April 2, 2021 |
|
$ | 10,910 | |||||||||||||||||||||||||
| Total Offering Amounts |
|
$ | 350,000,000 | $ | 32,445 | (4) | ||||||||||||||||||||||||||||||||||||
| Total Fees Previously Paid |
|
| ||||||||||||||||||||||||||||||||||||||||
| Total Fee Offsets |
|
$ | 10,910 | |||||||||||||||||||||||||||||||||||||||
| Net Fee Due |
|
$ | 21,535 | |||||||||||||||||||||||||||||||||||||||
| (1) | There is being registered hereunder an indeterminate number of shares of (a) common stock, (b) preferred stock, (c) debt securities, (d) warrants to purchase common stock, preferred stock or debt securities of the Registrant, (e) subscription rights to purchase common stock, preferred stock or debt securities of the Registrant, and (f) units, consisting of some or all of these securities in any combination, as may be sold from time to time by the Registrant. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. There is also being registered hereunder an indeterminate number of shares of common stock, preferred stock and debt securities as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance. In no event will the aggregate offering price of all types of securities issued by the Registrant pursuant to this registration statement exceed $350,000,000. |
| (2) | Pursuant to Rule 416(a), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction. |
| (3) | The proposed maximum offering price per share and proposed maximum aggregate offering price for each type of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder. |
| (4) | Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes $10,910 previously paid by the Registrant in connection with the registration of $100,000,000 of shares of common stock previously registered pursuant to this Registration Statement, none of which were sold as of the date hereof. |
| (5) | The securities registered pursuant to this Registration Statement include unsold securities previously registered by the Registrant on this registration statement for the offer and sale of up to $100,000,000 in shares of the Registrants common stock (the Unsold Shelf Securities), all of which remains unsold as the date of filing of this Post-Effective Amendment No. 1 to this Registration Statement. Pursuant to Rule 457(b) under the Securities Act, the filing fee of $10,910 relating to the Unsold Shelf Securities, will continue to be applied to the Unsold Shelf Securities registered pursuant to this Registration Statement. |
Table 2: Fee Offset Claims and Sources
| Registrant or |
Form or Filing Type |
File Number |
Initial Filing Date |
Filing Date | Fee Offset Claimed |
Security Type Associated with Fee Offset Claimed |
Security Title Associated with Fee Offset Claimed |
Unsold Securities Associated with Fee Offset Claimed |
Unsold Aggregate Offering Amount Associated with Fee Offset Claimed |
Fee Paid with Fee Offset Source |
||||||||||||||||||||||||||||||||||
| Rule 457(b) and 0-11(a)(2) |
||||||||||||||||||||||||||||||||||||||||||||
| Fee Offset Claims |
|
| | | | |||||||||||||||||||||||||||||||||||||||
| Fee Offset Sources |
Sutro Biopharma, Inc. | S-3ASR | 333-255014 | April 2, 2021 | April 2, 2021 | $10,910 | Equity | |
Common Stock, par value $0.0001 per |
|
N/A | $ | 100,000,000 | $ | 10,910 | |||||||||||||||||||||||||||||
| Rule 457 (p) |
||||||||||||||||||||||||||||||||||||||||||||
| Fee Offset |
| | | | | | | | | |||||||||||||||||||||||||||||||||||
| Claims |
| | | | | |||||||||||||||||||||||||||||||||||||||